Loading...
OTCM
BOIRF
Market cap621mUSD
Nov 13, Last price  
30.00
Name

Boiron SA

Chart & Performance

D1W1MN
OTCM:BOIRF chart
P/E
P/S
EPS
0.65
Div Yield, %
4.88%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
-2.63%
Revenues
488m
-1.15%
361,646,000398,674,000434,471,000466,894,000526,279,000520,600,000523,452,000566,294,000617,988,000609,984,000607,962,000614,491,000617,542,000604,216,000557,123,000513,582,000455,201,000534,239,000493,248,000487,559,000
Net income
11m
-68.36%
16,415,00010,245,00027,157,00039,184,00059,889,00043,283,00042,264,00049,626,00082,396,00089,049,00073,932,00077,725,00078,243,00057,459,00040,630,00026,209,00028,556,00044,673,00035,827,00011,336,000
CFO
42m
-7.30%
41,738,00038,569,00056,130,00065,479,00080,202,00051,638,00058,821,00088,594,000107,017,00096,156,000103,164,000110,131,000104,745,00084,250,00051,555,00068,676,00033,879,00060,099,00045,491,00042,168,000
Dividend
Jun 03, 20241.465 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
IPO date
Mar 25, 1991
Employees
2,813
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT